메뉴 건너뛰기




Volumn 37, Issue 2, 2011, Pages 475-476

Liver toxicity of sitaxentan in pulmonary arterial hypertension

Author keywords

[No Author keywords available]

Indexed keywords

AMBRISENTAN; BILE SALT; BOSENTAN; PREDNISONE; SITAXSENTAN;

EID: 79953665196     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00194810     Document Type: Letter
Times cited : (46)

References (6)
  • 1
    • 70349634397 scopus 로고    scopus 로고
    • Guidelines for the diagnosis and treatment of pulmonary hypertension
    • Galiè N, Hoeper MM, Humbert M, et al. Guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Respir J 2009; 34: 1219-1263.
    • (2009) Eur Respir J , vol.34 , pp. 1219-1263
    • Galiè, N.1    Hoeper, M.M.2    Humbert, M.3
  • 2
    • 0036283401 scopus 로고    scopus 로고
    • Clinical efficacy of sitaxsentan, an endothelin-A receptor antagonist, in patients with pulmonary arterial hypertension: Open-label pilot study
    • DOI 10.1378/chest.121.6.1860
    • Barst RJ, Rich S, Widlitz A, et al. Clinical efficacy of sitaxsentan, an endothelin-A receptor antagonist, in patients with pulmonary arterial hypertension: open-label pilot study. Chest 2002; 121: 1860-1868. (Pubitemid 34634407)
    • (2002) Chest , vol.121 , Issue.6 , pp. 1860-1868
    • Barst, R.J.1    Rich, S.2    Widlitz, A.3    Horn, E.M.4    McLaughlin, V.5    McFarlin, J.6
  • 3
    • 69249146238 scopus 로고    scopus 로고
    • Severe hepatitis associated with sitaxentan and response to glucocorticoid therapy
    • Hoeper MM, Olsson KM, Schneider A, et al. Severe hepatitis associated with sitaxentan and response to glucocorticoid therapy. Eur Respir J 2009; 33: 1518-1519.
    • (2009) Eur Respir J , vol.33 , pp. 1518-1519
    • Hoeper, M.M.1    Olsson, K.M.2    Schneider, A.3
  • 4
    • 79951848194 scopus 로고    scopus 로고
    • Sitaxentan-related acute liver failure in a patient with pulmonary arterial hypertension
    • Lee W-TN, Kirkham N, Johnson MK, et al. Sitaxentan-related acute liver failure in a patient with pulmonary arterial hypertension. Eur Respir J 2011; 37: 472-474.
    • (2011) Eur Respir J , vol.37 , pp. 472-474
    • Lee, W.-T.N.1    Kirkham, N.2    Johnson, M.K.3
  • 5
    • 70349091119 scopus 로고    scopus 로고
    • Sitaxentan-induced hepatic failure in two patients with pulmonary arterial hypertension
    • Lavelle A, Sugrue R, Lawler G, et al. Sitaxentan-induced hepatic failure in two patients with pulmonary arterial hypertension. Eur Respir J 2009; 34: 770-771.
    • (2009) Eur Respir J , vol.34 , pp. 770-771
    • Lavelle, A.1    Sugrue, R.2    Lawler, G.3
  • 6
    • 79951848803 scopus 로고    scopus 로고
    • Date last updated: December 11, Date last accessed: December 16, 2010
    • European Medicines Agency. Thelin (sitaxentan) to be withdrawn due to cases of unpredictable serious liver injury. www.ema.europa. eu/ema/index.jsp?curl5pages/news-and-events/news/2010/12/news-detail-001161. jsp&murl5menus/news-and-events/news-and-events.jsp& mid5WC0b01ac058004d5c1&jsenabled5true Date last updated: December 11, 2010. Date last accessed: December 16, 2010.
    • (2010) Thelin (Sitaxentan) to Be Withdrawn Due to Cases of Unpredictable Serious Liver Injury


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.